NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹65 Cr | ₹89 Cr | ₹92 Cr | ₹72 Cr | ₹61 Cr |
What is the latest Contingent Liabilities ratio of NATH BIOGENES (INDIA) ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹65 Cr |
| Mar2025 | ₹89 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹72 Cr |
| Mar2022 | ₹61 Cr |
How is Contingent Liabilities of NATH BIOGENES (INDIA) Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹65 Cr | -27.09 | |
| Mar2025 | ₹89 Cr | -3.34 | |
| Mar2024 | ₹92 Cr | 28.60 | |
| Mar2023 | ₹72 Cr | 18.58 | |
| Mar2022 | ₹61 Cr | - | |
Compare Contingent Liabilities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹265.5 Cr | -6.7% | -11.6% | -17.9% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹3,679.2 Cr | -11.3% | -5.9% | -33.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,262.9 Cr | -2.8% | -2.5% | 8.2% | Stock Analytics | |
| AVT NATURAL PRODUCTS | ₹1,338.7 Cr | -5.1% | -0.8% | 26.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹892.0 Cr | -3.4% | -3.7% | NA | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹505.5 Cr | -4% | 9% | -11.3% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -6.7% |
-11.6% |
-17.9% |
| SENSEX | -2.3% |
-6.6% |
-12% |
You may also like the below Video Courses